![Giacomo Chiesi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Giacomo Chiesi
Directeur/Membre du Conseil chez
CHIESI Farmaceutici SpA
Profil
Mr. Giacomo Chiesi is a Managing Partner at Chiesi Ventures, Inc. He is on the Board of Directors at Sentien Biotechnologies, Inc. and CHIESI Farmaceutici SpA. Mr. Chiesi was previously employed as a Founder by CHIESI BV, a Founder by Chiesi Ltd., a Founder by Chiesi Pharma AB, and a Board Member by Glycomine, Inc.
Postes actifs de Giacomo Chiesi
| Sociétés | Poste | Début |
|---|---|---|
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Directeur/Membre du Conseil | - |
Sentien Biotechnologies, Inc.
 Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Develops cell-based therapy | Directeur/Membre du Conseil | - |
Chiesi Ventures, Inc.
 Chiesi Ventures, Inc. Investment ManagersFinance Chiesi Ventures invests in companies located in the United States and Europe. The firm targets companies operating in the fields of rare and orphan disorders. It provides financing from seed and early stage capital requirements with an investment size of USD 4 - 5 million and acts as a lead investor. | Private Equity Investor | 01/01/2014 |
Anciens postes connus de Giacomo Chiesi
| Sociétés | Poste | Fin |
|---|---|---|
Chiesi Ltd.
 Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Fondateur | - |
Chiesi SA (Belgium)
 Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Engages in research, development and production of medicines for respiratory & neonatology areas | Fondateur | - |
Chiesi Pharma AB
 Chiesi Pharma AB BiotechnologyHealth Technology Engages in research & development, manufactures and sells medicines | Fondateur | - |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Chiesi Ltd.
Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Health Technology |
Chiesi SA (Belgium)
Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Engages in research, development and production of medicines for respiratory & neonatology areas | Health Technology |
Sentien Biotechnologies, Inc.
Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Develops cell-based therapy | Health Technology |
Chiesi Ventures, Inc.
Chiesi Ventures, Inc. Investment ManagersFinance Chiesi Ventures invests in companies located in the United States and Europe. The firm targets companies operating in the fields of rare and orphan disorders. It provides financing from seed and early stage capital requirements with an investment size of USD 4 - 5 million and acts as a lead investor. | Finance |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Health Technology |
Chiesi Pharma AB
Chiesi Pharma AB BiotechnologyHealth Technology Engages in research & development, manufactures and sells medicines | Health Technology |
